BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SAR445399 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SAR445399\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07225569-11339@assetmemo.bio
DTSTAMP:20261121T005706Z
DTSTART;VALUE=DATE:20270922
DTEND;VALUE=DATE:20270923
SUMMARY:SAR445399: Phase 2 readout est. (NCT07225569)
DESCRIPTION:SAR445399\, phase 2\, Hidradenitis Suppurativa.\nStudy: A Study
  to Investigate Efficacy and Safety With SAR445399 in Adult Participants W
 ith Moderate to Severe Hidradenitis Suppurativa\nEstimated primary complet
 ion: 22 September 2027. This is a ClinicalTrials.gov estimate\, not a conf
 irmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dr
 ug/sar445399#upcoming-events\nRegistry record: https://clinicaltrials.gov/
 study/NCT07225569
URL:https://assetmemo.bio/drug/sar445399#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
